Angiotensin II Type 1 Receptor Blockers Concept

subject area of

• ACE Inhibitors in Heart Failure  Journal Articles
• Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes  Journal Articles
• Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial  Journal Articles
• Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry  Journal Articles
• Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction  Journal Articles
• Albuminuria in chronic heart failure: prevalence and prognostic importance  Journal Articles
• Angiotensin Blockade Does Not Affect Fibrosis Progression in Recurrent Hepatitis C After Liver Transplantation  Journal Articles
• Angiotensin II mobilizes intracellular calcium and activates pannexin‐1 channels in rat carotid body type II cells via AT₁ receptors  Journal Articles
• Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels  Journal Articles
• Arterial stiffness and pharmacological interventions--the TRanscend arterial stiffNess Substudy (TRANS study).  Journal Articles
• Assessment of Long-Term Effects of Irbesartan on Heart Failure With Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial  Journal Articles
• Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure  Journal Articles
• Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation  Journal Articles
• Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction  Journal Articles
• Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme  Journal Articles
• Blocking the renin–angiotensin system: dual- versus mono-therapy  Journal Articles
• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies  Journal Articles
• Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system  Journal Articles
• Candesartan for the management of heart failure: more than an alternative  Journal Articles
• Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk  Journal Articles
• Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM  Journal Articles
• Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response  Journal Articles
• Chinese herbal medicine Shenzhuo Formula treatment in patients with macroalbuminuria secondary to diabetic kidney disease: study protocol for a randomized controlled trial  Journal Articles
• Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and Angina  Journal Articles
• Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme  Journal Articles
• Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I‐PRESERVE) trial  Journal Articles
• Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts  Journal Articles
• Contribution of cardiac and extra‐cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure  Journal Articles
• Covariate adjusted reanalysis of the I-Preserve trial  Journal Articles
• Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program  Journal Articles
• Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction  Journal Articles
• Dual Renin-Angiotensin System Blockade in Heart Failure  Journal Articles
• Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients  Journal Articles
• Effect of Telmisartan on Renal Outcomes  Journal Articles
• Effects of Candesartan on the Development of a New Diagnosis of Diabetes Mellitus in Patients With Heart Failure  Journal Articles
• Effects of Losartan on Patients Hospitalized for Acute Coronavirus Disease 2019: A Randomized Controlled Trial  Journal Articles
• Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study  Journal Articles
• Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker  Journal Articles
• Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function  Journal Articles
• Epidemiology of Decompensated Heart Failure in a Single Community in the Northeastern United States  Journal Articles
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both  Journal Articles
• Exploring design-related bias in clinical studies on receptor genetic polymorphism of hypertension  Journal Articles
• Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction  Journal Articles
• Heart failure with mid‐range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum  Journal Articles
• Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial  Journal Articles
• Heart failure.  Journal Articles
• Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND  Journal Articles
• Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure  Journal Articles
• Impact of blood pressure lowering, cholesterol lowering and their combination in Asians and non-Asians in those without cardiovascular disease: an analysis of the HOPE 3 study  Journal Articles
• Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure  Journal Articles
• Improved Outcomes With Early Collaborative Care of Ambulatory Heart Failure Patients Discharged From the Emergency Department  Journal Articles
• Incidence and Predictors of Hyperkalemia in Patients With Heart Failure  Journal Articles
• Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure  Journal Articles
• Inhibition of Marfan Syndrome Aortic Root Dilation by Losartan  Journal Articles
• Initial data supporting the design of the Candesartan in Heart failure — Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction  Journal Articles
• Irbesartan in Patients with Atrial Fibrillation  Journal Articles
• Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction  Journal Articles
• Is the jury out? Class specific differences on coronary outcomes with ACE-inhibitors and ARBs: insight from meta-analysis and The Blood Pressure Lowering Treatment Trialists' CollaborationThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.  Journal Articles
• Is therapy of people with chronic kidney disease ONTARGET?  Journal Articles
• Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure  Journal Articles
• Metabolic effects of telmisartan in subjects with abdominal obesity: A prospective randomized controlled trial  Journal Articles
• Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction  Journal Articles
• Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction  Journal Articles
• Myocardial Infarction in Heart Failure With Preserved Ejection Fraction  Journal Articles
• Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics  Journal Articles
• Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Journal Articles
• Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines  Journal Articles
• Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction  Journal Articles
• Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme  Journal Articles
• Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme  Journal Articles
• Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors  Journal Articles
• Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program  Journal Articles
• Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.  Journal Articles
• Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction  Journal Articles
• Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction  Journal Articles
• Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction  Journal Articles
• Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program  Journal Articles
• RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection  Journal Articles
• Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events  Journal Articles
• Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)  Journal Articles
• Relation of Peripheral Collagen Markers to Death and Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction  Journal Articles
• Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I‐Preserve)  Journal Articles
• Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial  Journal Articles
• Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure  Journal Articles
• Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial  Journal Articles
• Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD  Journal Articles
• Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme  Journal Articles
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Journal Articles
• Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus  Journal Articles
• Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction  Journal Articles
• Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction  Journal Articles
• Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation  Journal Articles
• Systolic and Diastolic Blood Pressure Changes in Relation With Myocardial Infarction and Stroke in Patients With Coronary Artery Disease  Journal Articles
• Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events  Journal Articles
• Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data.  Journal Articles
• The CHARM program: the effects of candesartan for the management of patients with chronic heart failure  Journal Articles
• The CHARM programme  Journal Articles
• The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and Design  Journal Articles
• The Mini‐Mental State Examination, Clinical Factors, and Motor Vehicle Crash Risk  Journal Articles
• The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial  Journal Articles
• Usefulness of Temporal Changes in Neurohormones as Markers of Ventricular Remodeling and Prognosis in Patients With Left Ventricular Systolic Dysfunction and Heart Failure Receiving Either Candesartan or Enalapril or Both  Journal Articles
• Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy  Journal Articles
• Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme  Journal Articles
• Worsening Renal Function and Outcome in Heart Failure Patients With Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment  Journal Articles